BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of xenobiotics
,
Inflammatory disorder
,
Lung
,
Autoimmunity
,
Clofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
extracellular signal- regulated map kinases
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Feedback mechanism in depolarization-induced sustained activation of extracellular signal-regulated …
A kinetic model of ERK cyclic pathway on substrate control.
Multistationarity in mass action networks with applications to ERK activation.
Potential opposite roles of the extracellular signal-regulated kinase (ERK) pathway in autism spectr…
Metal-dependent protein phosphatase 1A functions as an extracellular signal-regulated kinase phospha…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform…
Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With…
Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis
BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ